Tobacco Products
-
Smoking Cessation Products to Help You Quit
FDA Approved Smoking Cessation Products Currently Marketed
as of June 12, 2009
To find further information on the products listed below visit Drugs@FDA.
Proprietary Name Formulation | NDA |
---|---|
Nicotrol NS(nicotine nasal spray, 0.5 mg/spray) (Pfizer) Generics – No | 020385 |
Nicotrol Inhaler (nicotine inhalation system, 4 mg/cartridge) (Pharmacia) (n.b., despite the name this product delivers via the oral transmucosal route) Generics – No | 020714 |
Chantix(varenicline tartrate) (Pfizer) Generics – No | 021928 |
Zyban(bupropion hydrochloride sustained release) (GSK) Generics – Yes | 020711 |
Nicorette Gum | 018612 |
Nicorette DS Gum | 020066 |
Habitrol Transdermal film | 020076 |
Nicoderm CQ Transdermal system | 020165 |
Commit lozenge | 021330 |
Nicorette lozenge | 022360 |
Proprietary Name | Applicant Name | ANDA |
---|---|---|
bupropion hydrochloride | Actavis | 77-475 |
bupropion hydrochloride | IMPAX Laboratories | 75-914 |
bupropion hydrochloride | Sandoz | 76-834 |
Nicotine Film, Extended Release, 7MG | Aveo | 74645 |
Nicotine Film, Extended Release, 14MG | Aveo | 74611 |
Nicotine Film, Extended Release, 21MG | Aveo | 74612 |
Nicotine Polacrilex, Gum, Chewing; Buccal, EQ 2MG | Ivax Pharmaceuticals | 76880 |
Nicotine Polacrilex, Gum, Chewing; Buccal, EQ 4MG | Ivax Pharmaceuticals | 77850 |
Thrive (Nicotine Polacrilex) Gum, Chewing ; Buccal, EQ 2MG | Novartis | 77658 |
Thrive (Nicotine Polacrilex) Gum, Chewing ; Buccal, EQ 4MG | Novartis | 77656 |
Nicotine Polacrilex, Gum, Chewing ; Buccal, EQ 2MG | Perigo | 76775, 76777 |
Nicotine Polacrilex, Gum, Chewing ; Buccal, EQ 4MG | Perigo | 76778, 76779, 76789 |
Nicotine Polacrilex, Gum, Chewing ; Buccal, EQ 2MG | Perigo Research and Development | 78325, 78547, 78967 |
Nicotine Polacrilex, Gum, Chewing ; Buccal, EQ 4MG | Perigo Research and Development | 78326, 78546, 78968 |
Nicotine Polacrilex, Gum, Chewing ; Buccal, EQ 2MG | Watson Laboratories | 74507, 76569, 78699 |
Nicotine Polacrilex, Gum, Chewing ; Buccal, EQ 4MG | Watson Laboratories | 74707, 76568, 78697 |
Nicotine Polacrilex, Troche/Lozenge, EQ 2MG | Perigo Research and Development | 77007 |
For OTC Products:
- All of the OTC smoking cessation products are approved for OTC use in adults 18 years of age and older.
- Users under the age of 18 are to ask a doctor before use.
- People who continue to smoke, chew tobacco, use snuff or use a nicotine patch or other nicotine containing products should not use.
- All OTC products have the same indication
-
-